WILLIAMS DOUGLAS E
Insider CIK 1184847 · ONTY Director · IRWD Director · RGLS Director · OVID Director · CDAK See Remarks, Director · CAMP Director · CLYM Director · SANA EVP & President, R&D · BIIB EVP Research & Development
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CAMP Camp4 Therapeutics Corp | A Award deriv | 2026-06-10 | 2026-06-12 | 28,000 | — | $0 | 28,000 | SEC↗ |
| CLYM Climb Bio, Inc. | A Award deriv | 2026-06-05 | 2026-06-08 | 40,000 | — | $0 | 40,000 | SEC↗ |
| CLYM Climb Bio, Inc. | A Award deriv | 2025-06-04 | 2025-06-05 | 40,000 | — | $0 | 40,000 | SEC↗ |
| CLYM Climb Bio, Inc. | A Award deriv | 2025-03-31 | 2025-04-01 | 78,873 | — | $0 | 78,873 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | A Award deriv | 2025-03-17 | 2025-03-19 | 17,787 | — | $0 | 17,787 | SEC↗ |
| CLYM Climb Bio, Inc. | A Award deriv | 2024-11-11 | 2024-11-12 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CLYM Climb Bio, Inc. | A Award deriv | 2024-11-11 | 2024-11-12 | 6,291 | — | $0 | 6,291 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2024-03-07 | 2024-03-08 | 301,875 | — | $0 | 301,875 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2024-03-07 | 2024-03-08 | 67,083 | — | $0 | 67,083 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2023-11-02 | 2023-11-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2023-04-10 | 2023-04-11 | 1,100,000 | — | $0 | 1,100,000 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | S Sale | 2023-03-28 | 2023-03-30 | 41,667 | $0.18 | $7.5K | 7,655 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | S Sale | 2023-02-17 | 2023-02-21 | 7,681 | $0.59 | $4.5K | 49,322 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | M Exercise deriv | 2023-02-16 | 2023-02-21 | 22,969 | — | $0 | 45,937 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | M Exercise | 2023-02-16 | 2023-02-21 | 22,969 | — | $0 | 57,003 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | A Award deriv | 2023-01-24 | 2023-01-26 | 465,000 | — | $0 | 465,000 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | S Sale | 2023-01-20 | 2023-01-23 | 5,075 | $0.58 | $2.9K | 18,177 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | M Exercise deriv | 2023-01-19 | 2023-01-23 | 13,667 | — | $0 | 27,333 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | M Exercise | 2023-01-19 | 2023-01-23 | 13,667 | — | $0 | 23,252 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | S Sale | 2022-08-17 | 2023-02-21 | 7,112 | $2.21 | $15.7K | 34,034 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | M Exercise deriv | 2022-08-16 | 2023-02-21 | 22,969 | — | $0 | 68,906 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | M Exercise | 2022-08-16 | 2023-02-21 | 22,969 | — | $0 | 41,146 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | A Award deriv | 2022-02-16 | 2022-02-18 | 61,250 | — | $0 | 61,250 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | A Award deriv | 2022-02-16 | 2022-02-18 | 91,875 | — | $0 | 91,875 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | A Award deriv | 2022-01-19 | 2022-01-21 | 200,000 | — | $0 | 200,000 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | A Award deriv | 2022-01-19 | 2022-01-21 | 41,000 | — | $0 | 41,000 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2021-05-17 | 2021-05-18 | 1,750 | — | $0 | 1,750 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | A Award deriv | 2021-01-22 | 2021-01-26 | 175,000 | — | $0 | 175,000 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion deriv | 2020-10-16 | 2020-10-20 | 66,004 | — | $0 | 0 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion | 2020-10-16 | 2020-10-20 | 9,585 | — | $0 | 9,585 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2020-06-05 | 2020-06-08 | 13,250 | — | $0 | 13,250 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2019-11-13 | 2019-11-15 | 7,437 | — | $0 | 7,437 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2019-06-10 | 2019-08-01 | 5,813 | — | $0 | 5,813 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2019-06-07 | 2019-06-10 | 5,813 | — | $0 | 5,813 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | D To issuer | 2019-04-01 | 2019-04-03 | 4,056 | — | $0 | 87,800 | SEC↗ |
| OVID Ovid Therapeutics Inc. | P Buy | 2018-08-14 | 2018-08-16 | 5,000 | $6.49 | $32.5K | 5,000 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2018-06-07 | 2018-06-08 | 5,813 | — | $0 | 5,813 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2018-05-31 | 2018-06-04 | 16,223 | — | $0 | 91,856 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2017-05-31 | 2017-06-02 | 15,625 | — | $0 | 75,633 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2016-06-02 | 2016-06-03 | 36,620 | — | $0 | 36,620 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2016-06-01 | 2016-06-03 | 23,674 | — | $0 | 60,008 | SEC↗ |
| BIIB BIOGEN INC. | S Sale | 2015-06-19 | 2015-06-22 | 3,841 | $410.00 | $1.57M | 11,817 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2015-06-10 | 2015-06-26 | 17,500 | — | $0 | 17,500 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2015-06-03 | 2015-06-05 | 16,556 | — | $0 | 36,334 | SEC↗ |
| BIIB BIOGEN IDEC INC. | A Award deriv | 2015-02-23 | 2015-02-25 | 8,300 | — | $0 | 8,300 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2015-02-12 | 2015-02-17 | 1,627 | — | $0 | 6,383 | SEC↗ |
| BIIB BIOGEN IDEC INC. | J Other deriv | 2015-02-12 | 2015-02-17 | 1,041 | — | $0 | 5,342 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2015-02-12 | 2015-02-17 | 3,573 | — | $0 | 7,149 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2015-02-12 | 2015-02-17 | 3,573 | — | $0 | 16,481 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2015-02-12 | 2015-02-17 | 1,683 | $392.11 | $659.9K | 14,798 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2015-02-12 | 2015-02-17 | 1,627 | — | $0 | 16,425 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2015-02-12 | 2015-02-17 | 767 | $392.11 | $300.7K | 15,658 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2015-02-08 | 2015-02-10 | 3,468 | — | $0 | 3,471 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2015-02-08 | 2015-02-10 | 1,634 | $402.00 | $656.9K | 12,908 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2015-02-08 | 2015-02-10 | 3,468 | — | $0 | 14,542 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2015-02-01 | 2015-02-02 | 5,157 | — | $0 | 0 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2015-02-01 | 2015-02-02 | 2,059 | $389.16 | $801.3K | 11,074 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2015-02-01 | 2015-02-02 | 5,157 | — | $0 | 13,133 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2014-06-03 | 2014-06-05 | 19,778 | — | $0 | 19,778 | SEC↗ |
| """RGLS""" Regulus Therapeutics Inc. | A Award deriv | 2014-05-22 | 2014-05-22 | 17,500 | — | $0 | 17,500 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2014-03-19 | 2014-03-21 | 1,595 | $352.29 | $561.9K | 9,886 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2014-03-19 | 2014-03-21 | 994 | $352.29 | $350.2K | 7,976 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2014-03-19 | 2014-03-21 | 916 | $352.29 | $322.7K | 8,970 | SEC↗ |
| BIIB BIOGEN IDEC INC. | A Award deriv | 2014-02-12 | 2014-02-14 | 8,010 | — | $0 | 8,010 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2014-02-12 | 2014-02-14 | 3,573 | — | $0 | 10,722 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2014-02-12 | 2014-02-14 | 1,685 | $323.04 | $544.3K | 11,481 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2014-02-12 | 2014-02-14 | 3,573 | — | $0 | 13,166 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2014-02-08 | 2014-02-11 | 3,468 | — | $0 | 6,939 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2014-02-08 | 2014-02-11 | 1,636 | $315.54 | $516.2K | 9,593 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2014-02-08 | 2014-02-11 | 3,468 | — | $0 | 11,229 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2014-02-01 | 2014-02-03 | 5,159 | — | $0 | 5,157 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2014-02-01 | 2014-02-03 | 1,969 | $312.64 | $615.6K | 7,761 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2014-02-01 | 2014-02-03 | 5,159 | — | $0 | 9,730 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-08-26 | 2013-08-28 | 4,368 | $211.35 | $923.2K | 4,571 | SEC↗ |
| ONTY Oncothyreon Inc. | A Award deriv | 2013-06-13 | 2013-06-14 | 16,042 | — | $0 | 16,042 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2013-06-10 | 2013-06-10 | 17,500 | — | $0 | 17,500 | SEC↗ |
| ONTY Oncothyreon Inc. | F Tax w/h | 2013-06-09 | 2013-06-11 | 1,135 | $1.86 | $2.1K | 19,961 | SEC↗ |
| BIIB BIOGEN IDEC INC. | A Award deriv | 2013-02-12 | 2013-02-14 | 14,295 | — | $0 | 14,295 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2013-02-08 | 2013-02-12 | 3,006 | — | $0 | 10,869 | SEC↗ |
| BIIB BIOGEN IDEC INC. | J Other deriv | 2013-02-08 | 2013-02-12 | 462 | — | $0 | 10,407 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2013-02-08 | 2013-02-12 | 3,006 | — | $0 | 10,191 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2013-02-08 | 2013-02-12 | 1,252 | $164.44 | $205.9K | 8,939 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2013-02-01 | 2013-02-05 | 5,159 | — | $0 | 10,316 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2013-02-01 | 2013-02-05 | 5,159 | — | $0 | 8,864 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2013-02-01 | 2013-02-05 | 1,679 | $157.30 | $264.1K | 7,185 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2012-11-05 | 2012-11-08 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ONTY Oncothyreon Inc. | A Award | 2012-06-07 | 2012-06-08 | 8,174 | $3.67 | $30.0K | 21,096 | SEC↗ |
| ONTY Oncothyreon Inc. | F Tax w/h | 2012-06-03 | 2012-06-05 | 2,021 | $3.51 | $7.1K | 12,922 | SEC↗ |
| ONTY Oncothyreon Inc. | J Other | 2012-03-16 | 2012-06-05 | 2,320 | — | $0 | 14,943 | SEC↗ |
| BIIB BIOGEN IDEC INC. | A Award deriv | 2012-02-08 | 2012-02-10 | 13,875 | — | $0 | 13,875 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2012-02-01 | 2012-02-03 | 5,159 | — | $0 | 15,475 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2012-02-01 | 2012-02-03 | 5,159 | — | $0 | 5,562 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2012-02-01 | 2012-02-03 | 1,656 | $121.26 | $200.8K | 3,906 | SEC↗ |